As of 2026-01-07, the Relative Valuation of 4D Molecular Therapeutics Inc (FDMT) is (65.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.19 USD, the upside of 4D Molecular Therapeutics Inc based on Relative Valuation is -1013.9%.
The range of the Relative Valuation is (44.95) - (81.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 22.4x | 17.8x |
| Forward P/E multiples | 12.3x - 29.0x | 18.1x |
| Fair Price | (44.95) - (81.86) | (65.71) |
| Upside | -725.2% - -1238.5% | -1013.9% |
| Date | P/E |
| 2025-12-26 | -2.18 |
| 2025-12-24 | -2.21 |
| 2025-12-23 | -2.16 |
| 2025-12-22 | -2.38 |
| 2025-12-19 | -2.37 |
| 2025-12-18 | -2.37 |
| 2025-12-17 | -2.52 |
| 2025-12-16 | -3.15 |
| 2025-12-15 | -2.99 |
| 2025-12-12 | -2.96 |
| 2025-12-11 | -2.98 |
| 2025-12-10 | -2.96 |
| 2025-12-09 | -2.87 |
| 2025-12-08 | -3.03 |
| 2025-12-05 | -2.92 |
| 2025-12-04 | -3.06 |
| 2025-12-03 | -2.92 |
| 2025-12-02 | -2.77 |
| 2025-12-01 | -2.87 |
| 2025-11-28 | -3.19 |
| 2025-11-26 | -3.00 |
| 2025-11-25 | -2.92 |
| 2025-11-24 | -2.97 |
| 2025-11-21 | -2.96 |
| 2025-11-20 | -2.82 |
| 2025-11-19 | -2.95 |
| 2025-11-18 | -2.76 |
| 2025-11-17 | -2.99 |
| 2025-11-14 | -2.95 |
| 2025-11-13 | -2.81 |
| 2025-11-12 | -3.00 |
| 2025-11-11 | -2.95 |
| 2025-11-10 | -2.78 |
| 2025-11-07 | -2.87 |
| 2025-11-06 | -2.98 |
| 2025-11-05 | -2.87 |
| 2025-11-04 | -2.94 |
| 2025-11-03 | -3.06 |
| 2025-10-31 | -3.14 |
| 2025-10-30 | -3.09 |
| 2025-10-29 | -3.12 |
| 2025-10-28 | -3.27 |
| 2025-10-27 | -3.35 |
| 2025-10-24 | -3.10 |
| 2025-10-23 | -2.73 |
| 2025-10-22 | -2.87 |
| 2025-10-21 | -3.07 |
| 2025-10-20 | -3.08 |
| 2025-10-17 | -2.69 |
| 2025-10-16 | -2.76 |